Literature DB >> 31469207

Primary ciliary dyskinesia gene contribution in Tunisia: Identification of a major Mediterranean allele.

Rahma Mani1,2, Sabrina Belkacem1, Zohra Soua2, Sandra Chantot3, Guy Montantin1, Sylvie Tissier1, Bruno Copin1, Jihene Bouguila4, Nicolas Rive Le Gouard1, Lamia Boughamoura4, Salma Ben Ameur5, Mongia Hachicha5, Raoudha Boussoffara6, Khadija Boussetta7, Samia Hammouda7, Abir Bedoui4, Habib Besbes8, Seif Meddeb7, Karima Chraeit9, Monia Khlifa10, Estelle Escudier1, Serge Amselem1, Imed Mabrouk2, Marie Legendre1.   

Abstract

Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disease of motile cilia. Even though PCD is widely studied, North-African patients have been rarely explored. In this study, we aim at confirming the clinical diagnosis and explore the genetic spectrum of PCD in a cohort of Tunisian patients. Forty clinically diagnosed patients with PCD belonging to 34 families were recruited from Tunisian pediatric departments. In each proband, targeted capture PCD panel sequencing of the 40 PCD genes was performed. PCD panel sequencing identified bi-allelic mutations in 82% of the families in eight PCD genes. Remarkably, 23.5% of patients carried the same c.2190del CCDC39 mutation. Single nucleotide polymorphism profiling in six unrelated patients carrying this mutation has revealed a founder effect in North-African patients. This mutation is estimated to date back at least 1,400-1,750 years ago. The identification of this major allele allowed us to suggest a cost-effective genetic diagnostic strategy in North-African patients with PCD.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CCDC39; Kartagener syndrome; cilia; founder effect; primary ciliary dyskinesia

Mesh:

Substances:

Year:  2019        PMID: 31469207     DOI: 10.1002/humu.23905

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Biallelic Variants in CCDC39 Gene Lead to Primary Ciliary Dyskinesia and Kartagener Syndrome.

Authors:  Xiao Shi; Hao Geng; Hui Yu; Xiaolong Hu; Guanxiong Wang; Jin Yang; Hui Zhao
Journal:  Biomed Res Int       Date:  2022-06-26       Impact factor: 3.246

2.  Clinical and molecular characteristics of primary ciliary dyskinesia: A tertiary care centre experience.

Authors:  Mohammed Alzaid; Khalid Al-Mobaireek; Mohammed Almannai; Gawahir Mukhtar; Safa Eltahir; Adnan Zafar; Abdulali P Zada; Wadha Alotaibi
Journal:  Int J Pediatr Adolesc Med       Date:  2021-03-11

3.  Clinical and Genetic Spectrum of Children With Primary Ciliary Dyskinesia in China.

Authors:  Yuhong Guan; Haiming Yang; Xingfeng Yao; Hui Xu; Hui Liu; Xiaolei Tang; Chanjuan Hao; Xiang Zhang; Shunying Zhao; Wentong Ge; Xin Ni
Journal:  Chest       Date:  2021-02-10       Impact factor: 9.410

4.  The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis.

Authors:  William B Hannah; Bryce A Seifert; Rebecca Truty; Maimoona A Zariwala; Kristen Ameel; Yi Zhao; Keith Nykamp; Benjamin Gaston
Journal:  Lancet Respir Med       Date:  2022-01-17       Impact factor: 102.642

5.  Case Report: Identification of a Novel ODAD3 Variant in a Patient With Primary Ciliary Dyskinesia.

Authors:  Rongchun Wang; Danhui Yang; Ting Guo; Cheng Lei; Xu Chen; Xi Kang; Jie Qing; Hong Luo
Journal:  Front Genet       Date:  2021-02-26       Impact factor: 4.599

6.  Spectrum of Genetic Variants in a Cohort of 37 Laterality Defect Cases.

Authors:  Dinu Antony; Elif Gulec Yilmaz; Alper Gezdirici; Lennart Slagter; Zeineb Bakey; Helen Bornaun; Ibrahim Cansaran Tanidir; Tran Van Dinh; Han G Brunner; Peter Walentek; Sebastian J Arnold; Rolf Backofen; Miriam Schmidts
Journal:  Front Genet       Date:  2022-04-13       Impact factor: 4.772

7.  Clinical characteristics and genetic spectrum of 26 individuals of Chinese origin with primary ciliary dyskinesia.

Authors:  Xinyue Zhao; Chun Bian; Keqiang Liu; Wenshuai Xu; Yaping Liu; Xinlun Tian; Jing Bai; Kai-Feng Xu; Xue Zhang
Journal:  Orphanet J Rare Dis       Date:  2021-07-01       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.